... the USD 150,000 figure also explains why the canine cancer, antiviral pathways, etc might be on pause for the time being. One would think that the distributors would rather not have the same drug available at 5000 per year from a vet.
This all sounds a bit sad, but hopefully they can find a way to get MPL to whomever can benefit from it
Ann: PharmAust to present at NWR Virtual Healthcare Conference, page-12
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.42M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.3¢ | 19.0¢ | $25.41K | 133.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5372 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 262575 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |